Psoriasis Clinical Trials
Current / Recent Psoriasis Clinical Trials. Click title to view trial details.
- Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis
- Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
- Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
- Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
- A Post Marketing Observational Study (PMOS) of the Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biological Disease Modifying Anti-rheumatic Drugs (BDMARDs) Over 1 Year
- Prevalence of Sleep Disturbances in Psoriasis
- Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
- Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
- Peds Metabolic Syndrome in Psoriasis
- A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
- A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
- The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients
- Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
- Psoriasis Longitudinal Assessment and Registry (PSOLAR)
- Premature Coronary Artery Disease (CAD) in Severe Psoriasis
- CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
- A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
- Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
- Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
- A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
- Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
- A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
- Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis
- Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
- Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
- Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
- Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis
- Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
- A Study for Adults With Plaque Psoriasis
- A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
- A Study of Efalizumab in Patients With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
- A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
- Double-Blind, Randomised, Placebo-Controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
- Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
- Adalimumab in Adult Japanese Subjects With Psoriasis
- Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
- Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
- A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
- Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
- Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis
- A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
- Double-Blind, Randomized, Placebo-Controlled Comparison of CC10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
- A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
- Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
- Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
- Randomized Study of PH-10 for Psoriasis
- A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
- AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis
- Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
- A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
- A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
- A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis.
- A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
- Raptiva in Palm and Sole Psoriasis
- Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
- Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab
- Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
- A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
- Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)
|
Bookmark this post:
|
|
Posts
